Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page adds a reference to Hepatocellular carcinoma and includes the Genetic and Rare Diseases Information Center as a resource. It also updates the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T20:14:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T07:19:52.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:47:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.0 to v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T17:12:24.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous v3.3.3. This appears to be a minor version update to the page template.
    Difference
    0.0%
    Check dated 2026-01-15T03:16:22.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    The page's Locations list was updated with numerous additions and deletions across the United States, Canada, Europe, Australia, and Asia. This changes the study's geographic footprint and which sites are available to potential participants.
    Difference
    3%
    Check dated 2025-12-17T19:57:23.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.